Education
About Us
Working with TipRanks
Follow Us
Abeona Therapeutics Inc (CH:PCJ)
:PCJ
Total Valuation
Abeona Therapeutics has a market cap or net worth of ―. The enterprise value is $305.72M.
Market Cap―
Enterprise Value$305.72M
Share Statistics
Abeona Therapeutics has ― shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding―
Owned by Insiders6.59%
Owned by Institutions0.03%
Financial Efficiency
Abeona Therapeutics’s return on equity (ROE) is -1.45 and return on invested capital (ROIC) is -64.80%.
Return on Equity (ROE)-1.45
Return on Assets (ROA)-0.59
Return on Invested Capital (ROIC)-64.80%
Return on Capital Employed (ROCE)-0.70
Revenue Per Employee0.00
Profits Per Employee-468.63K
Employee Count136
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Abeona Therapeutics is -3.59. Abeona Therapeutics’s PEG ratio is -0.14.
PE Ratio-3.59
PS Ratio―
PB Ratio7.34
Price to Fair Value5.19
Price to FCF-4.72
Price to Operating Cash Flow-5.07
PEG Ratio-0.14
Income Statement
In the last 12 months, Abeona Therapeutics had revenue of 0.00 and earned -63.73M in profits. Earnings per share was -1.55.
Revenue0.00
Gross Profit0.00
Operating Income-64.21M
Pretax Income-63.73M
Net Income-63.73M
EBITDA-64.21M
Earnings Per Share (EPS)-1.55
Cash Flow
In the last 12 months, operating cash flow was -59.88M and capital expenditures -3.12M, giving a free cash flow of -63.00M billion.
Operating Cash Flow-59.88M
Free Cash Flow-63.00M
Free Cash Flow per Share―
Dividends & Yields
Abeona Therapeutics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta―
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)―
Important Dates
Abeona Therapeutics upcoming earnings date is Aug 18, 2025, TBA Not Confirmed.
Last Earnings DateMay 15, 2025
Next Earnings DateAug 18, 2025
Ex-Dividend Date―
Financial Position
Abeona Therapeutics as a current ratio of 6.08, with Debt / Equity ratio of 57.92%
Current Ratio6.08
Quick Ratio6.08
Debt to Market Cap0.08
Net Debt to EBITDA<0.01
Interest Coverage Ratio-15.26
Taxes
In the past 12 months, Abeona Therapeutics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Abeona Therapeutics EV to EBITDA ratio is -3.56, with an EV/FCF ratio of -3.91.
EV to Sales0.00
EV to EBITDA-3.56
EV to Free Cash Flow-3.91
EV to Operating Cash Flow-4.08
Balance Sheet
Abeona Therapeutics has $84.16M in cash and marketable securities with $23.98M in debt, giving a net cash position of -$60.18M billion.
Cash & Marketable Securities$84.16M
Total Debt$23.98M
Net Cash-$60.18M
Net Cash Per Share―
Tangible Book Value Per Share$1.07
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Abeona Therapeutics is $16.93, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$16.93
Price Target Upside― Downside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast―
EPS Growth Forecast―